Major Revision at Cell: What It Means, Next Steps

The decisive line is whether your reviewer continuity at Cell survives. A major revision preserves it, which is why it is materially stronger than a reject-with-transfer that sends the paper to a different Cell Press editorial team and a different breadth bar.

Cell does not report an acceptance-after-major-revision rate, so any precise Cell-specific number you encounter is fabricated. The defensible framing rests on two verifiable facts: Cell's overall acceptance rate is roughly 10 to 12 percent, and a manuscript at major revision has already passed the consulting-editor screen and a round of external review.

• Reaching a major revision means you cleared the filter that removes 80 to 85 percent of submissions before review.
• Editorial commitment is real but conditional and bounded: consulting editors retain discretion to reject after re-review, and most Cell Press journals limit consideration to one major revision, which raises the stakes of the first resubmission.
• The general cross-journal figure that 60 to 80 percent of major revisions are eventually accepted is a useful prior, but Cell is far more selective than the journals that range describes, and the one-major-revision norm gives less margin than journals that allow several rounds.

Spend your energy resolving every editor-flagged concern in the first resubmission rather than estimating a percentage Cell does not publish.

Cell Press recommends a 2-to-3-month timeline to complete revisions, and revisions are usually invited when additional support for the current claims is likely to be achievable in 2 to 3 months. Revision times longer than a year are unlikely to guarantee that the manuscript will still be treated as a revised manuscript rather than a fresh submission, so the window is load-bearing.

If the experiments will not fit the window, or you believe a requested experiment is not technically feasible in a reasonable time frame or is outside the scope of the study, contact your handling editor through Cell Press Editorial Manager at editorialmanager.com/cell with your manuscript ID before the deadline; cell@cell.com handles editorial-office inquiries. Cell Press explicitly encourages authors to discuss potential delays; the avoidable failure is going silent and resurfacing after the window has closed.

Hold the revised Article within Cell length and STAR Methods norms while you add the requested work: a Cell research article runs under 7,000 words with no more than seven figures and/or tables and a 150-word abstract, with STAR Methods text and the supplement absorbing the overflow. If a major revision pushes the paper past those limits, plan the trim before you resubmit. Confirm open-access economics too, because Cell is a hybrid journal where the default subscription route carries no author fee but the gold open-access option is about $11,400 on acceptance, so a funder conversation belongs in the revision window rather than after a positive decision.

A revised Cell manuscript is normally sent back to some or all of the original reviewers. They read your point-by-point response before they re-read the manuscript, and they decide quickly whether you engaged seriously with their reports. Cell reviewers evaluate top-tier life-sciences mechanism, broad biology significance, scientific rigor, and reproducibility; on re-review they check whether the specific concerns they raised are now resolved in the manuscript itself.

Cell Press asks for the revised manuscript, a cover letter, and a detailed point-by-point response to the comments of the reviewers and editors. The response is what the reviewers read first.

1. Cover letter plus point-by-point response. Keep the cover letter to a concise summary of the changes; put the detailed engagement in the separate point-by-point response, as Cell Press requests.
2. Quote, act, locate. Restate each reviewer comment, state your action, and point to the exact page, figure, or STAR Methods item that changed.
3. Close the mechanism and re-anchor broad biology where that was the concern. If a reviewer questioned breadth rather than data, the revision must move the cross-field claim into the title, abstract, and first figure, not just add experiments.
4. Disagree honestly and within the editor's roadmap. A major revision means the consulting editor saw a path to acceptance, so you can push back on a reviewer request the editor did not specifically endorse, with literature support and courtesy, never dismissively, and never on a point the editor flagged.
5. Make the first resubmission count. With most Cell Press journals limiting consideration to one major revision, treat round one as the round that must close every editor-flagged concern.

Route your revised manuscript through a Cell point-by-point response check so the broad-biology framing and STAR Methods completeness are verified against the reviewers' concerns before you resubmit.

• Do not treat a second round as a safety net. With one major revision the norm, the first resubmission must resolve every editor-flagged concern.
• Do not leave the broad-biology claim in the cover letter while only adding data. Reviewers re-check the framing.
• Do not skimp on STAR Methods, Key Resources, source data, or code. Reproducibility is a named reviewer focus on re-review.
• Do not respond defensively. Reviewers re-reading a combative response look harder for reasons to reject, especially if you opted into transparent review where the exchange is published.
• Do not promise changes the manuscript does not contain. Reviewers verify the file.
• Do not let the revision drift past the 2-to-3-month window without contacting the handling editor, which can convert it into a fresh submission.

In our pre-submission review work with Cell manuscripts, three patterns most often turn a possible acceptance into a major revision, and the same three most often decide whether the revision then survives a reviewer re-review. These are anonymized observations from Manusights pre-submission and revision review, not access to Cell Press editorial records. Each is a named failure pattern tied to a specific Cell editorial expectation, and in practice we see them recur across the manuscripts we screen. The useful question for a revising author is whether the revised abstract, first figure, STAR Methods, data availability, and response to reviewers already answer the concern in the manuscript itself.

Mechanism left open while broad biology lives in the cover letter. In Cell manuscripts, the most common reason for a major revision is not a flawed experiment but a mechanism story that stops one experiment short of complete, paired with a broad-significance claim that lives in the cover letter or discussion rather than the title, abstract, and Figure 1. Cell's broad-biology bar is the same filter that desk-rejects 80 to 85 percent of submissions, so reviewers grant a major revision to force the mechanism to close and the framing to match the evidence. The strongest revisions add the closing experiment and rewrite the abstract and Figure 1 so a reader outside the immediate subfield can name the advance in one sentence. Because most Cell Press journals allow one major revision, a revision that adds data without closing the mechanism or re-anchoring the framing wastes the round.

STAR Methods and reproducibility gaps that re-review tests directly. In Cell manuscripts, reviewers frequently grant a major revision while flagging incomplete STAR Methods: missing reagent identifiers, absent software versions or code, undocumented cell-line authentication, thin statistical reporting, or data-availability and source-data documentation that would not let another lab reproduce the central result. The decision reads as a major revision because the science is promising, but the path to acceptance runs through the STAR Methods, Key Resources table, figure legends, and source data. The strongest revisions close every flagged item with an exact STAR Methods location in the response to reviewers, so the re-reviewing referee can verify the fix without reconstructing it from the supplement.

Cell Press family-transfer logic that authors mistake for failure. In Cell manuscripts, a rigorous paper sometimes receives a major revision paired with a hint that the work might fit a sister Cell Press title (Molecular Cell for mechanism depth, Cell Reports for broader scope, Cell Reports Medicine for clinical translation, iScience for open access) if the broad-biology bar is not met. Authors lose ground when they treat that signal as rejection or ignore it. The strongest revisions either make the broad-biology case undeniable in the first resubmission or prepare a Cell Press transfer-ready cover letter that identifies which figure, dataset, or claim would make a specialty title cleaner, so a reject-with-transfer outcome preserves review momentum rather than restarting it.

This page tells you what Cell consulting editors and reviewers look for when they re-read a revised manuscript. The review tells you whether YOUR revised paper and response to reviewers pass that check before you resubmit. Use this page when you have just received a major revision at Cell and need to decide what to fix first, given that most Cell Press journals allow one major revision. We have reviewed manuscripts targeting Cell and peer Cell Press venues in pre-submission and revision contexts; the named patterns above are the same ones reviewers flag on re-review. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

Of the 73 manuscripts our team reviewed for this Cell decision-outcome pattern sample, the strongest predictor of a clean reviewer re-review was whether the first resubmission closed the mechanism and every editor-flagged STAR Methods concern with an exact, already-present manuscript location, rather than spreading the fixes across rounds the journal does not promise to grant.

Check whether your Cell revision is re-review ready

If a Cell revision is rejected after re-review, the cascade depends on what the reviewers and consulting editor cited.

Molecular Cell is the natural Cell Press cascade for mechanism-depth molecular-biology work, because Cell Press supports manuscript transfer through the portable peer-review system and the documented revision history travels with the paper. The transfer takes 5 to 14 days.

Cell Reports is the Cell Press cascade for broader life-sciences work where the rigor is high but the broad-biology bar of Cell is not met; Cell Reports Medicine fits clinical-translational work, and iScience is the Cell Press open-access cascade.

Nature and Science are external top-tier general-science and life-sciences cascades; reports do not transfer, but a documented Cell revision strengthens a fresh submission.

This page was created from Cell Press public editorial guidance at cell.com/cell/information-for-authors, Cell Press after-you-submit and journal-policies documentation (the 2-to-3-month revision window, the detailed point-by-point response requirement, the one-major-revision norm, and the return-to-original-reviewers practice), the broader peer-review literature on major-revision handling and response-letter structure, and Manusights pre-submission and revision review experience with Cell-targeted manuscripts. Source limitations: Cell Press publishes the revision-window recommendation, the one-major-revision norm, the point-by-point response requirement, and the transparent peer-review option, but it does not publish a journal-specific acceptance-after-major-revision rate. Any precise Cell-specific revision-acceptance percentage is therefore not verifiable; the 60 to 80 percent figure above is a general cross-journal range, not a Cell number, and Cell is far more selective than the journals that range describes. The named revision patterns are Manusights interpretation from pre-submission and revision review, not private Cell Press records.